WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response

Volume: 8, Issue: 7, Pages: e2955 - e2955
Published: Jul 27, 2017
Abstract
There are clear gaps in our understanding of genes and pathways through which cancer cells facilitate survival strategies as they become chemoresistant. Paclitaxel is used in the treatment of many cancers, but development of drug resistance is common. Along with being an antimitotic agent paclitaxel also activates endoplasmic reticulum (ER) stress. Here, we examine the role of WWOX (WW domain containing oxidoreductase), a gene frequently lost in...
Paper Details
Title
WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response
Published Date
Jul 27, 2017
Volume
8
Issue
7
Pages
e2955 - e2955
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.